Financials
Income statement
Fiscal date | Feb 2025 | Nov 2024 | Aug 2024 | May 2024 |
---|---|---|---|---|
Total reported revenue | 6.7B | 7.0B | 7.0B | 6.8B |
Cost of revenue | 6.2B | 6.4B | 6.3B | 6.2B |
Gross profit | 576M | 606M | 663M | 608M |
Operating expense | ||||
Research & development | 7M | 8M | 10M | 9M |
Selling general and admin | 256M | 305M | 270M | 268M |
Other operating expenses | — | — | — | — |
Operating income | 298M | 280M | 370M | 319M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 37M | 38M | 41M | 38M |
Other income expense | -77M | -103M | -76M | -80M |
Pretax income | 184M | 139M | 253M | 201M |
Tax provision | 67M | 39M | 115M | 72M |
Net income | 117M | 100M | 138M | 129M |
Basic EPS | — | — | — | — |
Diluted EPS | — | — | — | — |
Basic average shares | — | — | — | — |
Diluted average shares | — | — | — | — |
EBITDA | 465M | 442M | 485M | 498M |
Net income from continuing op. | 117M | 100M | 138M | 129M |
Minority interests | 0 | 0 | 0 | 0 |
Preferred stock dividends | — | — | — | — |